Cargando…

Comparison of albumin and cabergoline in the prevention of ovarian hyperstimulation syndrome: A clinical trial study

Background: Ovarian hyperstimulation syndrome (OHSS) is the most serious and potentially life-threatening iatrogenic complication associated with ovarian stimulation during Assisted Reproductive Technology (ART) protocols. OHSS typically is a result of ovarian expression of vascular endothelial grow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torabizadeh, Aalie, Vahidroodsari, Fatemeh, Ghorbanpour, Zakieh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research and Clinical Center for Infertility 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941342/ https://www.ncbi.nlm.nih.gov/pubmed/24639705

Ejemplares similares

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial
por: Fouda, Usama M., et al.
Publicado: (2016)

Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?
por: Rubenfeld, Eryn Sara, et al.
Publicado: (2021)

Comparison of Cabergoline and Quinagolide in Prevention of Severe Ovarian Hyperstimulation Syndrome among Patients Undergoing Intracytoplasmic Sperm Injection
por: Taheripanah, Robabeh, et al.
Publicado: (2018)

Evaluation of intravenous hydroxylethyl starch, intravenous albumin 20%, and oral cabergoline for prevention of ovarian hyperstimulation syndrome in patients undergoing ovulation induction
por: Ghahiri, Ataollah, et al.
Publicado: (2015)

High Dose Cabergoline in Management of Bilateral Ovarian Hyperstimulation Syndrome: A Case Report
por: Manalai, Gulparkha, et al.
Publicado: (2021)

Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome
por: Naredi, Nikita, et al.
Publicado: (2013)

Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoing in vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study
por: Kılıç, Niyazi, et al.
Publicado: (2015)

Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome
por: Zhang, Qiaoli, et al.
Publicado: (2022)

Prevention of Ovarian Hyperstimulation Syndrome: A Review
por: Smith, Vinayak, et al.
Publicado: (2015)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome
por: Alama, Pilar, et al.
Publicado: (2013)

Unsuspected adverse effect of albumin in severe ovarian hyperstimulation syndrome: a case report
por: Darii, Natalia, et al.
Publicado: (2019)

Large-Volume Paracentesis, up to 27 L, With Adjuvant Vaginal Cabergoline in the Case of Severe Ovarian Hyperstimulation Syndrome with Successful Pregnancy Outcome: A Case Report
por: Agarwal, Nupur, et al.
Publicado: (2017)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
por: Huang, Jianfang, et al.
Publicado: (2022)

Ovarian cyst regression with levothyroxine in ovarian hyperstimulation syndrome associated with hypothyroidism
por: Langroudi, Roghieh Molaei, et al.
Publicado: (2013)

Clinical Features of Severe Ovarian Hyperstimulation Syndrome with Hydrothorax
por: Ma, Xiaowei, et al.
Publicado: (2023)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

Artificial colloids versus human albumin for the treatment of ovarian hyperstimulation syndrome: A retrospective cohort study
por: Minami, Tetsuji, et al.
Publicado: (2019)

Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy
por: Di Guardo, Federica, et al.
Publicado: (2023)

Comparison of the Effectiveness of Various Medicines in the Prevention of Ovarian Hyperstimulation Syndrome: A Network Meta-Analysis of Randomized Controlled Trials
por: Wu, Di, et al.
Publicado: (2022)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy
por: Marak, Creticus P., et al.
Publicado: (2013)

Radiological Illustration of Spontaneous Ovarian Hyperstimulation Syndrome
por: Mittal, Kartik, et al.
Publicado: (2015)

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
por: Gómez, Gemma Grau, et al.
Publicado: (2019)

Ovarian Hyperstimulation Syndrome: Current Views on Pathophysiology, Risk Factors, Prevention, and Management
por: Alper, Michael M, et al.
Publicado: (2009)

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment
por: Fiedler, Klaus, et al.
Publicado: (2012)

Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome
por: Movahedi, Shohreh, et al.
Publicado: (2016)

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma
por: Orvieto, Raoul
Publicado: (2013)

Management of severe ovarian hyperstimulation syndrome with thawed plasma
por: Kamath, Mohan S, et al.
Publicado: (2013)

Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
por: Lappas, V, et al.
Publicado: (1999)

Severe ovarian hyperstimulation syndrome leading to ICU admission
por: Singh, R. K., et al.
Publicado: (2010)

Nephrotic Sydrome Developing in Severe Ovarian Hyperstimulation Syndrome
por: Gungor Ugurlucan, Funda, et al.
Publicado: (2014)

Spontaneous Ovarian Hyperstimulation Syndrome in a Triplet Pregnancy
por: Agrawal, Nisha Rani, et al.
Publicado: (2012)

Ovarian hyperstimulation syndrome in a spontaneous singleton pregnancy
por: Cabar, Fábio Roberto
Publicado: (2016)

Spontaneous ovarian hyperstimulation syndrome: Report of two cases
por: Gui, Juan, et al.
Publicado: (2019)

Chorionic gonadotropin: Ovarian hyperstimulation syndrome: case report
Publicado: (2021)

Spontaneous Ovarian Hyperstimulation Syndrome Associated With Primary Hypothyroidism
por: Alzebidi, Jawharah A, et al.
Publicado: (2023)

Clinical outcomes of frozen embryo transfer cycles after freeze-all policy to prevent ovarian hyperstimulation syndrome
por: Shin, Jae Jun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0pteip760nd96s3lprk05dj4h4